West Pharmaceutical names new CEO; Evoke meets FDA manufacturing requirement;

> West Pharmaceutical Services ($WST) has named Eric Green as its new chief executive officer, replacing Donald Morel, Jr. Announcement

> The FDA continues to work with the Chinese government on visas to get more regulatory agency inspectors on the ground. Article

> Solana Beach, CA-abased Evoke Pharma ($EVOK) says it has met the FDA requirement of producing its gastrointestinal drug candidate to commercial scale. Release

> U.K.-based Juniper Pharma Services has won permission from U.K. regulator MHRA to manufacture and supply bulk unlicensed medicines. Report

Suggested Articles

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

Just weeks after selling the sterile manufacturing assets of its Kyowa operation in Japan, it has unloaded the rest of its Kyowa drugmaking operation.

India’s Aurobindo, which has yet to close its $1 billion deal to buy 300 Sandoz products in the U.S., continues to rack up FDA issues.